ITGAM and colitis: Studies have shown that CD11b ameliorates symptoms of colitis through IL-10 production [55]; therefore, in mice from Group A (DSS + Que), which showed greater values of CD11b expression, there would appear to be better mobilization of the immune system, which would attenuate the symptoms of the disease.